Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Ipilimumab × Clear all

NCT05112601 2026-03-18

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Phase 2 Recruiting

Endometrial Neoplasms, Carcinoma, Endometrioid